SCHEMBL30953316

SCHEMBL30953316

CC1CCC([C@H](NC(=O)OC(C)(C)C)C(=O)Nc2cc(OCc3ccccc3)ccn2)CC1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ AAK1 Q2M2I8 3/20 0.44
▸ MMP1 P03956 2/20 0.40
▸ CTSL P07711 1/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ BCL2 P10415 1/20 0.39
▸ YAP1 P46937 3/20 0.39
▸ MMP2 P08253 1/20 0.39
▸ MMP9 P14780 1/20 0.39
▸ ADAM17 P78536 1/20 0.39
▸ CNR1 P21554 1/20 0.38
▸ CNR2 P34972 1/20 0.38
▸ CTSS P25774 1/20 0.38
▸ PPARA Q07869 1/20 0.38
▸ PTPN1 P18031 1/20 0.37
▸ KLK7 P49862 1/20 0.37
▸ KLK5 Q9Y337 1/20 0.37
▸ LMNA P02545 1/20 0.37
▸ RAB9A P51151 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30953440 0.84 AAK1 (0.51) AAK1MMP1MMP2MMP9ADAM17
SCHEMBL27393615 0.84 AAK1 (0.48) AAK1MMP1KMT2ALMNARAB9A
SCHEMBL30953221 0.84 AAK1 (0.48) AAK1MMP1KMT2ALMNARAB9A
SCHEMBL30953339 0.83 AAK1 (0.50) AAK1MMP1MEN1KMT2ALMNA
SCHEMBL30953499 0.83 AAK1 (0.39) AAK1CTSLKLK7KLK5
SCHEMBL30953402 0.82 AAK1 (0.60) AAK1MMP1CTSSLMNARAB9A
SCHEMBL27393604 0.81 AAK1 (0.44) AAK1MMP1LMNARAB9A
SCHEMBL30953276 0.81 AAK1 (0.44) AAK1MMP1LMNARAB9A
SCHEMBL30953541 0.80 AAK1 (0.44) AAK1MMP1LMNARAB9A
SCHEMBL30953269 0.80 AAK1 (0.48) AAK1MMP1LMNARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4630115-A1 THERAPEUTIC COMPOUNDS Sanofi (FR) 2025-10-15 — — EP disclosed
WO-2024121427-A1 THERAPEUTIC COMPOUNDS SANOFI (FR) 2024-06-13 — — WO disclosed
Send feedback